B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

PPARA

MOLECULAR TARGET

peroxisome proliferator activated receptor alpha

UniProt: Q07869NCBI Gene: 546518 compounds

PPARA (peroxisome proliferator activated receptor alpha) is targeted by 18 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).

Compounds Targeting PPARA

Ranked by bioassay confidence score (PubChem active assay count × evidence quality).

#CompoundConfidenceActive Assays
1Oleic Acid1.795
2Fenofibrate1.795
3Linoleic Acid1.795
4Bezafibrate1.614
5Pioglitazone1.614
6alpha-Linolenic Acid1.393
7Clofibrate1.393
8Gemfibrozil1.393
9Myristic Acid1.393
10Arachidonic Acid1.102
11Berberine1.102
12Mepentol [Supplementary Concept]1.102
13gamma-Linolenic Acid1.102
14Prostaglandin D21.102
15Ursolic Acid0.691
16Aldosterone0.691
17Palmitic Acid0.691
18Troglitazone0.691

About PPARA as a Drug Target

PPARA (peroxisome proliferator activated receptor alpha) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 18 compounds with documented PPARA interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.

PPARA inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.